Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Small-Cell-Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00055965
What this trial is testing

Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or Carboplatin

Who this might be right for
Lung Cancer
The Christie NHS Foundation Trust 400
Not applicableStudy completedNCT01928836
What this trial is testing

Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China

Who this might be right for
Lung Neoplasms
Bai Chunxue 764
Not applicableStudy completedNCT01741636
What this trial is testing

Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer

Who this might be right for
Stage I Colon CancerStage I Rectal CancerStage IA Non-small Cell Lung Cancer+17 more
City of Hope Medical Center 30
Not applicableStudy completedNCT01598597
What this trial is testing

An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)

Who this might be right for
Breast CancerColorectal CancerNon-Small Cell Lung Cancer+2 more
Genentech, Inc. 276
Testing effectiveness (Phase 2)UnknownNCT01170923
What this trial is testing

FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Asan Medical Center 100
Early research (Phase 1)Ended earlyNCT03927573
What this trial is testing

Study With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PSCA Marker

Who this might be right for
Non-small Cell Lung CancerProstate CancerRenal Cancer+1 more
AvenCell Europe GmbH 23
Not applicableUnknownNCT06564870
What this trial is testing

Efficacy and Safety Study of DURVALUMAB Maintenance in Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Bronchial Cancer
University Hospital, Brest 200
Early research (Phase 1)Ended earlyNCT01891669
What this trial is testing

PF-06263507 In Patients With Advanced Solid Tumors

Who this might be right for
NeoplasmsCarcinoma, Non Small Cell LungBreast Neoplasms+1 more
Pfizer 26
Not applicableUnknownNCT01240369
What this trial is testing

Association Between VEGF-C and miRNA and Clinical Non-small Cell Lung Cancer and Esophagus Squamous Cell Carcinoma

Who this might be right for
VEGFC Protein in SerumVEGFC Protein in Non Small Cell Lung CancerVEGFC Protein in ESCC+2 more
China Medical University Hospital 250
Large-scale testing (Phase 3)Study completedNCT00003869
What this trial is testing

Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Stage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI) 186
Large-scale testing (Phase 3)Study completedNCT01652469
What this trial is testing

Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®.

Who this might be right for
Carcinoma, Non-Small-Cell Lung
ETOP IBCSG Partners Foundation 81
Testing effectiveness (Phase 2)Study completedNCT03535740
What this trial is testing

Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib

Who this might be right for
ALK-positive Advanced NSCLC
Ariad Pharmaceuticals 103
Very early researchStudy completedNCT04049474
What this trial is testing

Bronchoscopic Cryo-Immunotherapy of Lung Cancer

Who this might be right for
Advanced Non-small Cell Lung Cancer
NYU Langone Health 21
Large-scale testing (Phase 3)Looking for participantsNCT07185997
What this trial is testing

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Who this might be right for
Non-Small-Cell Lung CancerMetastatic Non-Small-Cell Lung CancerAdvanced Non-Small-Cell Lung Cancer+3 more
ArriVent BioPharma, Inc.
Testing effectiveness (Phase 2)UnknownNCT06231680
What this trial is testing

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

Who this might be right for
Lung Cancer, Nonsmall CellEsophageal Carcinoma
Henan Cancer Hospital 132
Early research (Phase 1)Active Not RecruitingNCT05068102
What this trial is testing

Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck (HNSCC)MelanomaNon-small Cell Lung Cancer (NSCLC)
Boehringer Ingelheim 14
Testing effectiveness (Phase 2)Study completedNCT00002972
What this trial is testing

Paclitaxel in Treating Patients With Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 25
Testing effectiveness (Phase 2)Study completedNCT02417701
What this trial is testing

Sapanisertib in Treating Patients With Stage IV or Recurrent Lung Cancer

Who this might be right for
Recurrent Lung Squamous Cell CarcinomaStage IV Lung Squamous Cell Carcinoma AJCC v7
National Cancer Institute (NCI) 34
Early research (Phase 1)Study completedNCT05226728
What this trial is testing

Pharmacokinetically-guided on the Individualization of Pembrolizumab Administration in the Treatment of Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 33
Testing effectiveness (Phase 2)Study completedNCT01725165
What this trial is testing

Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage IV Non-Small Cell Lung Cancer AJCC v7
M.D. Anderson Cancer Center 85
Next Page
480